20-hydroxy-5,8,11,14-eicosatetraenoic acid and 3-nitrotyrosine

20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with 3-nitrotyrosine in 2 studies

Compound Research Comparison

Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid)	Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid)	Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid)	Studies (3-nitrotyrosine)	Trials (3-nitrotyrosine)	Recent Studies (post-2010) (3-nitrotyrosine)
640	13	233	3,510	87	1,137

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, J; Falck, JR; Ishizuka, T; Laniado-Schwartzman, M; Manthati, VL; Singh, H; Vitto, MD	1
Chen, YJ; Li, J; Quilley, J	1

Other Studies

2 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and 3-nitrotyrosine

Article	Year
20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cells. The Journal of pharmacology and experimental therapeutics, 2008, Volume: 324, Issue:1 Topics: Cell Line; Cytochrome P-450 CYP4A; Cytokines; Dinoprost; Dinoprostone; Endothelial Cells; Humans; Hydroxyeicosatetraenoic Acids; I-kappa B Kinase; Intercellular Adhesion Molecule-1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Tyrosine	2008
Deficient renal 20-HETE release in the diabetic rat is not the result of oxidative stress. American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:5 Topics: Aldehyde Reductase; Animals; Antioxidants; Arachidonic Acid; Benzothiazoles; Cyclic N-Oxides; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP4A; Diabetes Mellitus, Experimental; Enzyme Induction; Enzyme Inhibitors; Fenofibrate; Hydroxyeicosatetraenoic Acids; Hypoglycemic Agents; Indomethacin; Insulin; Kidney; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Perfusion; Phthalazines; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Spin Labels; Tyrosine	2008

Article

Year

20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cells.

The Journal of pharmacology and experimental therapeutics, 2008, Volume: 324, Issue:1

Topics: Cell Line; Cytochrome P-450 CYP4A; Cytokines; Dinoprost; Dinoprostone; Endothelial Cells; Humans; Hydroxyeicosatetraenoic Acids; I-kappa B Kinase; Intercellular Adhesion Molecule-1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Tyrosine

2008

Deficient renal 20-HETE release in the diabetic rat is not the result of oxidative stress.

American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:5

Topics: Aldehyde Reductase; Animals; Antioxidants; Arachidonic Acid; Benzothiazoles; Cyclic N-Oxides; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP4A; Diabetes Mellitus, Experimental; Enzyme Induction; Enzyme Inhibitors; Fenofibrate; Hydroxyeicosatetraenoic Acids; Hypoglycemic Agents; Indomethacin; Insulin; Kidney; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Perfusion; Phthalazines; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Spin Labels; Tyrosine

2008